Slide background
test
test
test
Keep me informedREGISTER NOW

April 7–8
2022
Basel, Switzerland

Novel Antimicrobials & AMR Diagnostics

7th AMR Conference

AMR Conference

16-17 March 2023, Basel

SIGN UP FOR OUR NEWSLETTER

Please save the date for the upcoming

7th AMR Conference 2023

taking place 16-17 March at the Congress Center Basel.

Latest News

in the AMR and antimicrobial space

New modified antibiotic may prove effective against >200 resistant pathogens

To create a novel molecule that may be effective against resistant Gram-negative bacteria, researchers at University…

New WHO pipeline report on bacterial vaccines issued

Vaccines are powerful tools to prevent infections in the first place that could later on lead…

Biomérieux, Evotec and Boehringer Ingelheim team up in new €40m joint venture

The companies Biomériux, Evotec and Boehringer Ingelheim have joined forces against AMR and announced the launch…

Commonwealth leaders discuss AMR

Commonwealth leaders have convened in Kigali, Rwanda, to discuss the challenge of antimicrobial resistance and the…

New report issued by Global AMR R&D Hub and WHO

Increasing cases of antibiotic resistance endanger global health and the availability of modern healthcare. Till date,…

CARB-X receives additional US$ 370m from US Government and Wellcome Trust

CARB-X (part of Boston University) announces the renewal of its support from Wellcome Trust, a worldwide…

Vivli awarded contract by Wellcome Trust to improve use of AMR surveillance data

The availability of surveillance data on antimicrobial resistance (AMR) makes it possible to assess incidence rates…

COVID-19 pandemic may be accelerating antimicrobial resistance: new US study published

A new study by BD (Becton Dickinson) and MSD (Merck & Co.) found higher rates of…

UK to launch world-first subscription model for antibiotics

With the goal of counteracting the growing world-wide crisis over resistance to antibiotics, the United Kingdom…

About the conference

The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.

The “AMR Conference” was started in 2017 as part of the annual “Berlin Conference on Life Sciences” series which was established by BIOCOM AG twelve years ago as an event format to discuss the challenges of SME-driven innovation for the health market and to offer a platform for meeting experts from business, science, clinics, finance, regulatory affairs and intellectual property.

The BEAM Alliance is one of the major supporting partners of the AMR Conference. Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance is a strong network of more than 60 small and medium-sized European biotech and diagnostics companies committed to developing innovative products for fending off antibiotic-resistant pathogens. The aim is to establish the AMR Conference as the one-stop-shop in Europe to meet all AMR relevant stakeholders.

6th AMR Conference – What you can expect

The AMR Conference is a platform to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to market.

More than 400 delegates from 25+ countries

80+ high-level speakers in 20 sessions

Pre-conference workshops and satellite meetings

A variety of topics from R&D to financing, regulation & incentives

Poster session, exhibition and pre-scheduled 1:1 partnering meetings

SMEs, academics & governmental agencies benefit from discounted fees

Thanks to all our Supporting Partners of the 6th AMR Conference

                      

             

                                        

                                     

                            

                  

Sponsors and Exhibitors of the 7th AMR Conference

Supporting Partners

Media Partner